KBC Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.3M | Buy |
950,953
+274,144
| +41% | +$21.1M | 0.17% | 122 |
|
|
2025
Q4 | $53.7M | Buy |
676,809
+451,521
| +200% | +$35.6M | 0.12% | 146 |
|
|
2025
Q3 | $17M | Sell |
225,288
-10,556
| -4% | -$723K | 0.04% | 284 |
|
|
2025
Q2 | $16.3M | Sell |
235,844
-52,312
| -18% | -$3.43M | 0.04% | 294 |
|
|
2025
Q1 | $19.5M | Sell |
288,156
-1,367,334
| -83% | -$81.8M | 0.06% | 280 |
|
|
2024
Q4 | $74.3M | Sell |
1,655,490
-447,283
| -21% | -$25.1M | 0.2% | 105 |
|
|
2024
Q3 | $132M | Sell |
2,102,773
-1,251,527
| -37% | -$73M | 0.4% | 46 |
|
|
2024
Q2 | $198M | Buy |
3,354,300
+854,883
| +34% | +$53.5M | 0.6% | 24 |
|
|
2024
Q1 | $199M | Buy |
2,499,417
+1,349,740
| +117% | +$103M | 0.63% | 26 |
|
|
2023
Q4 | $90.8M | Sell |
1,149,677
-168,594
| -13% | -$12M | 0.32% | 70 |
|
|
2023
Q3 | $92M | Buy |
1,318,271
+349,299
| +36% | +$24.7M | 0.38% | 58 |
|
|
2023
Q2 | $67M | Sell |
968,972
-239,094
| -20% | -$17M | 0.28% | 76 |
|
|
2023
Q1 | $89.8M | Buy |
1,208,066
+128,220
| +12% | +$10.8M | 0.38% | 57 |
|
|
2022
Q4 | $101M | Buy |
1,079,846
+16,110
| +2% | +$1.55M | 0.49% | 45 |
|
|
2022
Q3 | $101M | Buy |
1,063,736
+176,686
| +20% | +$17.5M | 0.53% | 43 |
|
|
2022
Q2 | $82.2M | Buy |
887,050
+176
| +0% | +$17.2K | 0.41% | 57 |
|
|
2022
Q1 | $89.8M | Buy |
886,874
+698,640
| +371% | +$73.4M | 0.35% | 75 |
|
|
2021
Q4 | $19.4M | Sell |
188,234
-119,073
| -39% | -$11M | 0.06% | 263 |
|
|
2021
Q3 | $26.1M | Sell |
307,307
-534,521
| -63% | -$44.8M | 0.1% | 216 |
|
|
2021
Q2 | $70.2M | Buy |
841,828
+104,832
| +14% | +$8.58M | 0.13% | 185 |
|
|
2021
Q1 | $55.4M | Buy |
736,996
+5,428
| +0.7% | +$395K | 0.11% | 211 |
|
|
2020
Q4 | $275M | Sell |
731,568
-625,536
| -46% | -$40.7M | 0.12% | 198 |
|
|
2020
Q3 | $79.3M | Sell |
1,357,104
-36,840
| -3% | -$2.29M | 0.23% | 100 |
|
|
2020
Q2 | $90.6M | Buy |
1,393,944
+638,520
| +85% | +$40.2M | 0.3% | 73 |
|
|
2020
Q1 | $44.8M | Buy |
755,424
+436,354
| +137% | +$29.1M | 0.38% | 58 |
|
|
2019
Q4 | $23.7M | Sell |
319,070
-46,139
| -13% | -$3.24M | 0.15% | 169 |
|
|
2019
Q3 | $23M | Sell |
365,209
-66,758
| -15% | -$3.96M | 0.17% | 141 |
|
|
2019
Q2 | $23.5M | Buy |
431,967
+1,943
| +0.5% | +$105K | 0.18% | 137 |
|
|
2019
Q1 | $23.2M | Sell |
430,024
-363,448
| -46% | -$22.4M | 0.19% | 133 |
|
|
2018
Q4 | $52M | Sell |
793,472
-17,605
| -2% | -$1.31M | 0.58% | 31 |
|
|
2018
Q3 | $63.8M | Buy |
811,077
+644,481
| +387% | +$46.1M | 0.48% | 37 |
|
|
2018
Q2 | $10.7M | Sell |
166,596
-437,430
| -72% | -$28.8M | 0.09% | 270 |
|
|
2018
Q1 | $37.6M | Buy |
604,026
+44,199
| +8% | +$3.17M | 0.35% | 71 |
|
|
2017
Q4 | $40.6M | Buy |
559,827
+44,680
| +9% | +$3.25M | 0.35% | 71 |
|
|
2017
Q3 | $41.9M | Sell |
515,147
-178,911
| -26% | -$14.2M | 0.38% | 62 |
|
|
2017
Q2 | $55.8M | Sell |
694,058
-181,365
| -21% | -$14.3M | 0.54% | 37 |
|
|
2017
Q1 | $68.7M | Buy |
875,423
+290,969
| +50% | +$23.2M | 0.62% | 25 |
|
|
2016
Q4 | $46.1M | Buy |
584,454
+180,957
| +45% | +$14.6M | 0.46% | 45 |
|
|
2016
Q3 | $35.9M | Buy |
403,497
+7,121
| +2% | +$672K | 0.42% | 51 |
|
|
2016
Q2 | $38M | Buy |
396,376
+155,878
| +65% | +$15.5M | 0.54% | 32 |
|
|
2016
Q1 | $24.9M | Buy |
240,498
+36,754
| +18% | +$3.57M | 0.41% | 52 |
|
|
2015
Q4 | $19.9M | Buy |
203,744
+3,013
| +2% | +$295K | 0.37% | 57 |
|
|
2015
Q3 | $19.4M | Sell |
200,731
-86,197
| -30% | -$9.06M | 0.39% | 61 |
|
|
2015
Q2 | $30.1M | Sell |
286,928
-30,843
| -10% | -$3.15M | 0.39% | 61 |
|
|
2015
Q1 | $32.8M | Buy |
317,771
+38,682
| +14% | +$3.91M | 0.42% | 51 |
|
|
2014
Q4 | $26.9M | Buy |
279,089
+118,282
| +74% | +$10.4M | 0.32% | 70 |
|
|
2014
Q3 | $12.8M | Sell |
160,807
-142,021
| -47% | -$11.2M | 0.45% | 34 |
|
|
2014
Q2 | $22.8M | Buy |
302,828
+129,789
| +75% | +$9.81M | 0.26% | 80 |
|
|
2014
Q1 | $13M | Sell |
173,039
-33,723
| -16% | -$2.38M | 0.2% | 116 |
|
|
2013
Q4 | $14.8M | Sell |
206,762
-2,443
| -1% | -$157K | 0.22% | 110 |
|
|
2013
Q3 | $11.9M | Sell |
209,205
-91,619
| -30% | -$5.46M | 0.19% | 141 |
|
|
2013
Q2 | $17.2M | Buy |
+300,824
| New | +$17.4M | 0.32% | 77 |
|
Other funds holding CVS
VCM
VPM
KBC Group's CVS Position: Q1 2026 in Review
KBC Group increased its CVS Health (CVS) stake by 41% in Q1 2026, buying an estimated $21.1M and bringing the position to 950,953 shares worth $68.3M. The position accounts for 0.17% of the portfolio, ranked #122.
KBC Group first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $275M in Q4 2020. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- KBC Group held 950,953 shares of CVS Health worth $68.3M as of Q1 2026.
- KBC Group bought 274,144 CVS Health shares in Q1 2026, an estimated $21.1M.
- CVS Health made up 0.17% of KBC Group's portfolio in Q1 2026, its #122 holding.
- KBC Group first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- KBC Group's CVS Health position peaked at $275M in Q4 2020.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.